Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Neurogen Biomarking LLC
- Study ID
- NCT07701161
- Status
- Recruiting
Conditions
- Alzheimer s Disease
- Biomarkers
- MCI Conversion to Dementia
- pTau217
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 90 Years
- Healthy Volunteers
- Accepted
Study Details
This study compares p-tau217 concentrations in blood collected via the Tasso device versus standard venipuncture in subjects with and without Alzheimer's disease, including a subset with confirmed amyloid pathology.
Key Dates
- First listed
- Jul 14, 2026
- Start date
- Jan 13, 2025
- Status verified
- Jul 2026
- Primary completion
- Mar 20, 2026
- Completion
- Aug 1, 2026
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: AD subjectsAmyloid PET/CSF confirmed and clinically diagnosed
- Arm: Healthy ControlsNo history of cognitive impairment
- Arm: Non-AD cognitively impaired (amyloid-negative)Cognitive impairment not due to AD, confirmed amyloid-negative via PET/CSF
Primary Outcome Measure
Agreement between p-tau217 concentration in Tasso device capillary blood and venipuncture blood [ Time Frame: Baseline ]
Central Contacts
- Ansam Eghzawi, MD+18109410076
- Elisabeth Thijssen, PhD+16282788161
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Insigth Hospital and Medical Center Chicago | Chicago | Illinois | 60616 | |
| Insight Hospital and Medical Center Dearborn | Dearborn | Michigan | 48126 | - |
| Insight Institute of Neurology and Neurosurgery | Flint | Michigan | 48507 | - |
| Memorial Healthcare Hospital | Owosso | Michigan | 48867 | - |
| Wake Forest Baptist Medical Center | Winston-Salem | North Carolina | 27157 | - |
Find similar trials in Chicago, IL
Related Studies
- Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized PatientsRecruiting · University of Chicago · Chicago, Illinois
- Vanderbilt Memory and Aging ProjectRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)Recruiting · Oncology Center of Biochemical Education And Research · New York, New York
- PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)PHASE1 · Recruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland